Literature DB >> 34111469

Early-Life Microbial Restitution Reduces Colitis Risk Promoted by Antibiotic-Induced Gut Dysbiosis in Interleukin 10-/- Mice.

Jun Miyoshi1, Sawako Miyoshi2, Tom O Delmont3, Candace Cham4, Sonny T M Lee5, Aki Sakatani4, Karen Yang4, Yue Shan4, Megan Kennedy4, Evan Kiefl6, Mahmoud Yousef7, Sean Crosson8, Mitchell Sogin9, Dionysios A Antonopoulos10, A Murat Eren11, Vanessa Leone12, Eugene B Chang13.   

Abstract

BACKGROUND & AIMS: Perturbations in the early-life gut microbiome are associated with increased risk for complex immune disorders like inflammatory bowel diseases. We previously showed that maternal antibiotic-induced gut dysbiosis vertically transmitted to offspring increases experimental colitis risk in interleukin (IL) 10 gene deficient (IL10-/-) mice, a finding that may result from the loss/lack of essential microbes needed for appropriate immunologic education early in life. Here, we aimed to identify key microbes required for proper development of the early-life gut microbiome that decrease colitis risk in genetically susceptible animals.
METHODS: Metagenomic sequencing followed by reconstruction of metagenome-assembled genomes was performed on fecal samples of IL10-/- mice with and without antibiotic-induced dysbiosis to identify potential missing microbial members needed for immunologic education. One high-value target strain was then engrafted early and/or late into the gut microbiomes of IL10-/- mice with antibiotic-induced dysbiosis.
RESULTS: Early-, but not late-, life engraftment of a single dominant Bacteroides strain of non-antibiotic-treated IL10-/- mice was sufficient to restore the development of the gut microbiome, promote immune tolerance, and prevent colitis in IL10-/- mice that had antibiotic-induced dysbiosis.
CONCLUSIONS: Restitution of a keystone microbial strain missing in the early-life antibiotic-induced gut dysbiosis results in recovery of the microbiome, proper development of immune tolerance, and reduced risk for colitis in genetically prone hosts.
Copyright © 2021 AGA Institute. All rights reserved.

Entities:  

Keywords:  Dysbiosis; Immune Tolerance; Inflammatory Bowel Diseases; Keystone Microbes

Mesh:

Substances:

Year:  2021        PMID: 34111469      PMCID: PMC8577987          DOI: 10.1053/j.gastro.2021.05.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   33.883


  23 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

2.  The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice.

Authors:  Peter J Turnbaugh; Vanessa K Ridaura; Jeremiah J Faith; Federico E Rey; Rob Knight; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2009-11-11       Impact factor: 17.956

3.  Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.

Authors:  James D Lewis; Eric Z Chen; Robert N Baldassano; Anthony R Otley; Anne M Griffiths; Dale Lee; Kyle Bittinger; Aubrey Bailey; Elliot S Friedman; Christian Hoffmann; Lindsey Albenberg; Rohini Sinha; Charlene Compher; Erin Gilroy; Lisa Nessel; Amy Grant; Christel Chehoud; Hongzhe Li; Gary D Wu; Frederic D Bushman
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

4.  Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone Offspring.

Authors:  Jun Miyoshi; Alexandria M Bobe; Sawako Miyoshi; Yong Huang; Nathaniel Hubert; Tom O Delmont; A Murat Eren; Vanessa Leone; Eugene B Chang
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

5.  Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study.

Authors:  Anne K Örtqvist; Cecilia Lundholm; Jonas Halfvarson; Jonas F Ludvigsson; Catarina Almqvist
Journal:  Gut       Date:  2018-01-10       Impact factor: 23.059

6.  Engineering the gut microbiota to treat hyperammonemia.

Authors:  Ting-Chin David Shen; Lindsey Albenberg; Kyle Bittinger; Christel Chehoud; Ying-Yu Chen; Colleen A Judge; Lillian Chau; Josephine Ni; Michael Sheng; Andrew Lin; Benjamin J Wilkins; Elizabeth L Buza; James D Lewis; Yevgeny Daikhin; Ilana Nissim; Marc Yudkoff; Frederic D Bushman; Gary D Wu
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

7.  Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells.

Authors:  Dingding An; Sungwhan F Oh; Torsten Olszak; Joana F Neves; Fikri Y Avci; Deniz Erturk-Hasdemir; Xi Lu; Sebastian Zeissig; Richard S Blumberg; Dennis L Kasper
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

8.  Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice.

Authors:  Suzanne Devkota; Yunwei Wang; Mark W Musch; Vanessa Leone; Hannah Fehlner-Peach; Anuradha Nadimpalli; Dionysios A Antonopoulos; Bana Jabri; Eugene B Chang
Journal:  Nature       Date:  2012-07-05       Impact factor: 49.962

Review 9.  A Multihit Model: Colitis Lessons from the Interleukin-10-deficient Mouse.

Authors:  Lydia M Keubler; Manuela Buettner; Christine Häger; André Bleich
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

10.  Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice.

Authors:  Anjelique F Schulfer; Thomas Battaglia; Yelina Alvarez; Luc Bijnens; Victoria E Ruiz; Melody Ho; Serina Robinson; Tonya Ward; Laura M Cox; Arlin B Rogers; Dan Knights; R Balfour Sartor; Martin J Blaser
Journal:  Nat Microbiol       Date:  2017-11-27       Impact factor: 17.745

View more
  5 in total

Review 1.  Microbiota-assisted therapy for systemic inflammatory arthritis: advances and mechanistic insights.

Authors:  Bowen Li; Bo Yang; Xiaoming Liu; Jianxin Zhao; R Paul Ross; Catherine Stanton; Hao Zhang; Wei Chen
Journal:  Cell Mol Life Sci       Date:  2022-08-06       Impact factor: 9.207

2.  Ginger Extract Decreases Susceptibility to Dextran Sulfate Sodium-Induced Colitis in Mice Following Early Antibiotic Exposure.

Authors:  Xinghong Zhou; Xiaoyu Liu; Qiuxing He; Ming Wang; Hanqi Lu; Yanting You; Liqian Chen; Jingru Cheng; Fei Li; Xiuqiong Fu; Hiu Yee Kwan; Lin Zhou; Xiaoshan Zhao
Journal:  Front Med (Lausanne)       Date:  2022-01-05

Review 3.  Effect of the Microbiome on Intestinal Innate Immune Development in Early Life and the Potential Strategy of Early Intervention.

Authors:  Zhipeng Yang; Xiangchen Liu; Yanting Wu; Jian Peng; Hongkui Wei
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

4.  Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis.

Authors:  Jianqiu Xiao; Kai Sun; Chun Wang; Yousef Abu-Amer; Gabriel Mbalaviele
Journal:  J Transl Autoimmun       Date:  2022-08-30

5.  S. boulardii Early Intervention Maintains Gut Microbiome Structure and Promotes Gut Mucosal Barrier Function in Early-Weaned Rats.

Authors:  Zhipeng Yang; Yanting Wu; Xiangchen Liu; Mei Zhang; Jian Peng; Hongkui Wei
Journal:  Nutrients       Date:  2022-08-24       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.